영문목차

“The Asia-Pacific Surgical Robotics Market Expected to Reach $8,068.7 Million by 2032.”

Introduction to Asia-Pacific (APAC) Surgical Robotics Market

The Asia-Pacific (APAC) Surgical Robotics market is expected to grow at a CAGR of 17.29% from $1,637.6 Million in 2022 to $8,068.7 Million by 2032 in the forecasted period of 2022-2032. The expanding global trend toward minimally invasive surgical methods and the increased awareness among medical professionals about simulation, training, and ongoing medical education are expected to drive the anticipated growth of the Asia-Pacific (APAC) surgical robots market.

Market Introduction

As the region's healthcare system and medical processes continue to change, the surgical robotics market in Asia-Pacific (APAC) is expanding significantly. A growing inclination for less invasive surgical procedures and increased awareness among medical professionals of the advantages of training, simulation, and ongoing medical education are the main forces behind this expansion. Technological developments are not only revolutionizing surgical procedures but also improving patient outcomes and shortening recuperation periods. The APAC region is becoming a key player in the global surgical robotics market as more and more medical institutions and practitioners adopt surgical robotics. Adoption of these cutting-edge technology has the potential to completely transform healthcare in the future by improving operations' accuracy, efficiency, and minimal invasiveness.

Market Segmentation:

Segmentation 1: by Type

• Surgical Systems
• Instruments and Accessories
• Services

Segmentation 2: by Application

• General Surgery
• Urology Surgery
• Gynecology Surgery
• Orthopedic Surgery
• Cardiology Surgery
• Head and Neck (including Neurology) Surgery
• Other Surgeries

Segmentation 3: by Region

• Asia-Pacific - Japan, China, India, Australia and New Zealand, South Korea, Taiwan, Singapore, Thailand, Malaysia, Indonesia, and the Philippines

How can this report add value to an organization?

Product/Innovation Strategy: The type segment helps the reader understand the different types of surgical systems and accessories available for use in the surgical robotics industry.

Growth/Marketing Strategy: The APAC surgical robotics market has seen major development by key players operating in the market, such as business expansions, partnerships, collaborations, mergers and acquisitions, product launches, and funding activities. The favored strategy for the companies has been partnerships, alliances, and business expansions to strengthen their position in the surgical robotics market.

Competitive Strategy: Key players in the APAC surgical robotics market analyzed and profiled in the study involve players that offer surgical systems, instruments and accessories, and services. Moreover, a detailed market share analysis of the players operating in the APAC surgical robotics market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration.

Some of the prominent names established in this market are:

Table of Contents

1 Market

• 1.1 Industry Outlook
  • 1.1.1 Key Trends
  • 1.1.2 Opportunity Assessment
  • 1.1.3 Surgical Robotics Contract Manufacturer
  • 1.1.4 Comparative Analysis
    • 1.1.4.1 Conventional Surgery vs. Robotic Surgery
    • 1.1.4.2 Laparoendoscopic Single-Site Surgery (LESS) vs. Robotic Laparoendoscopic Single-Site Surgery (R-LESS)
  • 1.1.5 Case Study
    • 1.1.5.1 Sudhir Srivastava Innovations Pvt. Ltd.
    • 1.1.5.2 CMR Surgical Ltd.
  • 1.1.6 Key Enabling Technology
    • 1.1.6.1 Tetherless Insertable Surgical Camera (s-CAM) Robot
    • 1.1.6.2 Teleoperated Surgical System
  • 1.1.1 Patent Analysis
    • 1.1.1.1 Awaited Technological Developments
    • 1.1.1.2 Patent Analysis (by Year)
  • 1.1.2 Regulatory Scenario
    • 1.1.2.1 U.S.
      • 1.1.2.1.1 De-Novo Pathway
    • 1.1.2.2 European Union (EU)
      • 1.1.2.2.1 Impact of the EU's Medical Device Regulations (MDR)
        • 1.1.2.2.1.1 Expansion of Product Scope
        • 1.1.2.2.1.2 Reclassification of Medical Devices as per Associated Risk, Contact Duration, and Invasiveness
        • 1.1.2.2.1.3 More Supportive Clinical Investigations for Class III and Implantable Medical Devices
        • 1.1.2.2.1.4 Dedicated Personal for MDR Compliance
        • 1.1.2.2.1.5 More Emphasis on Post-Market Surveillance
        • 1.1.2.2.1.6 Requirement of Common Specifications
        • 1.1.2.2.1.7 Implementation of a Unique Device Identification (UDI) Mechanism
    • 1.1.2.3 China
    • 1.1.2.4 Japan
  • 1.1.3 Clinical Trials
  • 1.1.4 Product Pipeline
  • 1.1.5 Insights on Emerging Platforms in Pipeline
  • 1.1.6 End User Perception
  • 1.1.7 Value Chain Analysis
    • 1.1.7.1 Research and Product Development
    • 1.1.7.2 Manufacturing
    • 1.1.7.3 Testing and Quality Check
    • 1.1.7.4 Distribution and Post-Sale Services
  • 1.1.8 Price Analysis
  • 1.1.9 Business Model Analysis
    • 1.1.9.1 Business Model Analysis (by Type)
    • 1.1.9.2 Business Model Analysis (by Company)
      • 1.1.9.2.1 Business Model of Well-Established Players
      • 1.1.9.2.2 Business Model of Emerging Players
  • 1.1.10 Distribution Strategies
  • 1.1.11 Marketing Strategies
  • 1.1.12 Funding Scenario
  • 1.1.13 Technology Adoption Matrix
  • 1.1.14 Robotic-Assisted Surgery Adoption Across Surgical Applications
• 1.2 COVID-19 Impact
  • 1.2.1 Pre-COVID-19 Scenario
    • 1.2.1.1 Procedure Volumes
    • 1.2.1.2 Opportunities
  • 1.2.2 During COVID-19 Scenario
    • 1.2.2.1 Impact of COVID-19 on Hospitals and Manufacturers
      • 1.2.2.1.1 Impact of COVID-19 on Hospitals
      • 1.2.2.1.2 Impact of COVID-19 on Surgical System Manufacturers
    • 1.2.2.2 Focus Areas during COVID-19 Scenario
    • 1.2.2.3 Demand and Supply
    • 1.2.2.4 COVID-19 Impact Analysis of Surgical System Manufacturers
  • 1.2.3 Future Impact of COVID-19
    • 1.2.3.1 Impact on Demand and Supply
    • 1.2.3.2 Impact on Competitive Landscape
    • 1.2.3.3 Impact on Entry Barrier and Opportunities
• 1.3 Impact due to Russian-Ukraine War
  • 1.3.1 Impact on Healthcare Industry and Infrastructure
  • 1.3.2 Impact on the MedTech and the Surgical Robotics Industry

2 Asia-Pacific

• 2.1 Asia-Pacific
  • 2.1.1 Key Findings and Opportunity Assessment
  • 2.1.2 Market Dynamics
    • 2.1.2.1 Impact Analysis
  • 2.1.3 Unit Sold
  • 2.1.4 Installed Base
  • 2.1.5 Market Sizing and Forecast Analysis
    • 2.1.5.1 Asia-Pacific Surgical Robotics Market (by Type)
    • 2.1.5.2 Asia-Pacific Surgical Robotics Market (by Application)
    • 2.1.5.3 Asia-Pacific Surgical Robotics Market (by Country)
      • 2.1.5.3.1 Japan
        • 2.1.5.3.1.1 Market Dynamics
        • 2.1.5.3.1.2 Unit Sold
        • 2.1.5.3.1.3 Installed Base
        • 2.1.5.3.1.4 Market Size and Forecast
        • 2.1.5.3.1.4.1 Japan Surgical Robotics Market (by Type)
        • 2.1.5.3.1.4.2 Japan Surgical Robotics Market (by Application)
      • 2.1.5.3.2 China
        • 2.1.5.3.2.1 Market Dynamics
        • 2.1.5.3.2.2 Unit Sold
        • 2.1.5.3.2.3 Installed Base
        • 2.1.5.3.2.4 Market Size and Forecast
        • 2.1.5.3.2.4.1 China Surgical Robotics Market (by Type)
        • 2.1.5.3.2.4.2 China Surgical Robotics Market (by Application)
      • 2.1.5.3.3 India
        • 2.1.5.3.3.1 Market Dynamics
        • 2.1.5.3.3.2 Unit Sold
        • 2.1.5.3.3.3 Installed Base
        • 2.1.5.3.3.4 Market Size and Forecast
        • 2.1.5.3.3.4.1 India Surgical Robotics Market (by Type)
        • 2.1.5.3.3.4.2 India Surgical Robotics Market (by Application)
      • 2.1.5.3.4 South Korea
        • 2.1.5.3.4.1 Market Dynamics
        • 2.1.5.3.4.2 Unit Sold
        • 2.1.5.3.4.3 Installed Base
        • 2.1.5.3.4.4 Market Size and Forecast
        • 2.1.5.3.4.4.1 South Korea Surgical Robotics Market (by Type)
        • 2.1.5.3.4.4.2 South Korea Surgical Robotics Market (by Application)
      • 2.1.5.3.5 Australia and New Zealand
        • 2.1.5.3.5.1 Market Dynamics
        • 2.1.5.3.5.2 Unit Sold
        • 2.1.5.3.5.3 Installed Base
        • 2.1.5.3.5.4 Market Size and Forecast
        • 2.1.5.3.5.4.1 Australia and New Zealand Surgical Robotics Market (by Type)
        • 2.1.5.3.5.4.2 Australia and New Zealand Surgical Robotics Market (by Application)
      • 2.1.5.3.6 Taiwan
        • 2.1.5.3.6.1 Market Dynamics
        • 2.1.5.3.6.2 Unit Sold
        • 2.1.5.3.6.3 Installed Base
        • 2.1.5.3.6.4 Market Size and Forecast
        • 2.1.5.3.6.4.1 Taiwan Surgical Robotics Market (by Type)
        • 2.1.5.3.6.4.2 Taiwan Surgical Robotics Market (by Application)
      • 2.1.5.3.7 Singapore
        • 2.1.5.3.7.1 Market Dynamics
        • 2.1.5.3.7.2 Unit Sold
        • 2.1.5.3.7.3 Installed Base
        • 2.1.5.3.7.4 Market Size and Forecast
        • 2.1.5.3.7.4.1 Singapore Surgical Robotics Market (by Type)
        • 2.1.5.3.7.4.2 Singapore Surgical Robotics Market (by Application)
      • 2.1.5.3.8 Thailand
        • 2.1.5.3.8.1 Market Dynamics
        • 2.1.5.3.8.2 Unit Sold
        • 2.1.5.3.8.3 Installed Base
        • 2.1.5.3.8.4 Market Size and Forecast
        • 2.1.5.3.8.4.1 Thailand Surgical Robotics Market (by Type)
        • 2.1.5.3.8.4.2 Thailand Surgical Robotics Market (by Application)
      • 2.1.5.3.9 Malaysia
        • 2.1.5.3.9.1 Market Dynamics
        • 2.1.5.3.9.2 Unit Sold
        • 2.1.5.3.9.3 Installed Base
        • 2.1.5.3.9.4 Market Size and Forecast
        • 2.1.5.3.9.4.1 Malaysia Surgical Robotics Market (by Type)
        • 2.1.5.3.9.4.2 Malaysia Surgical Robotics Market (by Application)
      • 2.1.5.3.10 Indonesia
        • 2.1.5.3.10.1 Market Dynamics
        • 2.1.5.3.10.2 Unit Sold
        • 2.1.5.3.10.3 Installed Base
        • 2.1.5.3.10.4 Market Size and Forecast
        • 2.1.5.3.10.4.1 Indonesia Surgical Robotics Market (by Type)
        • 2.1.5.3.10.4.2 Indonesia Surgical Robotics Market (by Application)
      • 2.1.5.3.11 Philippines
        • 2.1.5.3.11.1 Market Dynamics
        • 2.1.5.3.11.1.1 Unit Sold
        • 2.1.5.3.11.1.2 Installed Base
        • 2.1.5.3.11.1.3 Market Size and Forecast
        • 2.1.5.3.11.1.3.1 Philippines Surgical Robotics Market (by Type)
        • 2.1.5.3.11.1.3.2 Philippines Surgical Robotics Market (by Application)
      • 2.1.5.3.12 Rest-of-Asia-Pacific
        • 2.1.5.3.12.1 Market Dynamics
        • 2.1.5.3.12.1.1 Unit Sold
        • 2.1.5.3.12.1.2 Installed Base
        • 2.1.5.3.12.1.3 Market Size and Forecast
        • 2.1.5.3.12.1.3.1 Rest-of-Asia-Pacific Surgical Robotics Market (by Type)
        • 2.1.5.3.12.1.3.2 Rest-of-Asia-Pacific Surgical Robotics Market (by Application)

3 Markets - Competitive Benchmarking and Company Profiles

• 3.1 Competitive Landscape
  • 3.1.1 Key Strategies and Developments
    • 3.1.1.1 Regulatory and Legal Activities
    • 3.1.1.2 Funding Activities
    • 3.1.1.3 New Offerings
    • 3.1.1.4 Mergers and Acquisitions
    • 3.1.1.5 Partnerships, Collaborations, and Business Expansions
  • 3.1.2 Key Development Analysis
• 3.2 Company Share Analysis
• 3.3 Company Profiles
  • 3.3.1 Curexo, Inc.
    • 3.3.1.1 Company Overview
    • 3.3.1.2 Role of the Curexo, Inc. in the Global Surgical Robotics Market
    • 3.3.1.3 Product Portfolio
    • 3.3.1.4 Recent Developments
    • 3.3.1.5 Analyst Perspective
  • 3.3.2 EndoMaster Pte Ltd
    • 3.3.2.1 Company Overview
    • 3.3.2.2 Role of EndoMaster Pte Ltd in the Asia-Pacific Surgical Robotics Market
    • 3.3.2.3 Product Portfolio
    • 3.3.2.4 Recent Developments
    • 3.3.2.5 Analyst Perspective
  • 3.3.3 meerecompany Inc.
    • 3.3.3.1 Company Overview
    • 3.3.3.2 Role of meerecompany Inc. in the Asia-Pacific Surgical Robotics Market
    • 3.3.3.3 Product Portfolio
    • 3.3.3.4 Recent Developments
    • 3.3.3.5 Analyst Perspective
  • 3.3.4 Medicaroid Corporation
    • 3.3.4.1 Company Overview
    • 3.3.4.2 Role of Medicaroid Corporation in the Asia-Pacific Surgical Robotics Market
    • 3.3.4.3 Product Portfolio
    • 3.3.4.4 Recent Developments
    • 3.3.4.5 Analyst Perspective